Assessment of neurotoxicity from potential medications for drug abuse: Ibogaine testing and brain imaging

Annals of the New York Academy of Sciences

Volumn 820, Issue , 1997, Pages 29-40

  Vocci, Frank J ^a   London, Edythe D ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; IBOGAINE;

BRAIN FUNCTION; CONFERENCE PAPER; DRUG DEPENDENCE; NEURORADIOLOGY; NEUROTOXICITY;

EID: 0030860687     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46187.x     Document Type: Conference Paper

References (42)

1. GOUTAREL, R. 1993. Pharmacodynamic and therapeutic applications of iboga and ibogaine. Psychedelic Monographs and Essays. 6: 71-111.
2. NARANJO, C. 1969. Psychotherapeutic possibilities of new fantasy-enhancing drugs. Clinical Toxicology 2: 209-224.
3. LOTSOF, H. 1986. Rapid method for interrupting the cocaine and amphetamine addiction syndrome. U.S. Patent No. 4,587,243.
4. GLICK, S. D., K. ROSSMAN, S. STEINDORF & J. N. CARLSON. 1991. Effects and after-effects of ibogaine on morphine self-administration in rats. Eur. J. Pharmacol. 195: 341-345.
5. CLICK, S. D., M. E. KEUHNKE, J. RAUCCI, T. E. WILSON, T. D. LARSON, R. W. KELLER & J. N. CARLSON. 1994. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: Relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Res. 657: 14-22.
6. CAPPENDIJK, S. L. T. & M. R. DZOLJIC. 1993. Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur. J. Pharmacol. 241: 261-265.
7. EFFECTS OF IBOGAINE ON SELF-ADMINISTRATION OF COCAINE, HEROIN, AND FOOD IN RATS. 1993. Presented to the Food and Drug Administration's Drug Abuse Advisory Committee #26.
8. MANSBACH, R. S., R. L. BALSTER, M. GREGORY & E. SOENGHEN. 1992. Effects of ibogaine pretreatment on iv cocaine self-administration in rhesus monkey. NIDA Contract Report SA92.16.
9. DEECHER, D. C., M. TEITLER, D. M. SODERLUND, W. G. BORNMANN, M. E. KEUHNE & S. D. GLICK. 1992. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res. 1: 242-247.
10. REPKE, D. B., D. R. ARTIS, J. T. NELSON & E. H. F. WONG. 1994. Abbreviated ibogaine congeners. Synthesis and reaction of tropan-3-yl-2 and 3-indoles. Investigation of an unusual isomerization of 2-substituted indoles using computational and spectroscopic technique. J Org Chem. 59: 2164-2171.
11. SWEETNAM, P. J., J. LANCASTER, A. SNOWMAN, J. COLLINS, S. PERSCHKE, C. BAUER & J. FERKANY. 1995. Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity. Psychopharmacology (Berl). 118: 369-376.
12. PEARL, S. M., K. HERRICK-DAVIS, M. TEITILER & S. D. GLICK. 1995. Radioligand-binding study of noribogaine, a likely metabolite of ibogaine. Brain Res. 675: 342-344.
13. LONDON, E. D., S. J. GRANT, M. J. MORGAN & S. R. ZUKIN. 1996. Neurobiology of drug abuse. In Neuropsychiatry. B. S. Fogel, R. B. Schiffer, S. M. Rao, Eds. 635-678. William & Wilkins. Baltimore, MD.
14. DI CHIARA, G. & A. IMPERATO. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278.
15. MAISONNEUVE, I. M., R. W. KELLER & S. D. GLICK. 1990. Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats. Brain Res. 535: 221-226.
16. MOGHADDAM, B. & B. S. BUNNEY. 1989. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: Comparison to amphetamine. Synapse 4: 156-161.
17. MAISONNEUVE, I. M., R. W. KELLER & S. D. CLICK. 1991. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. Eur. J. Pharmacol. 199: 35-42.
18. MAISONNEUVE, I. M., K. L. ROSSMAN, R. W. KELLER, JR. & S. D. GLICK. 1992. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats. Brain Res. 575: 69-73.
19. MAISONNEUVE, I. M., R. W. KELLER & S. D. GLICK. 1992. Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats. Brain Res. 579: 87-92.
20. MAISONNEUVE, I. M. & S. D. GLICK. 1992. Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. Eur. J. Pharmacol. 212: 263-266.
21. PAGE, J. G., L. E. RODAN, D. R. FARNELL & J. F. MARTIN. 1994. Repeat dose oral toxicity study of ibogaine in rats. NIDA Contract Report SRI-CBE-94-002-7486-LXXII.
22. O'HEARN, E., D. B. LONG & M. E. MOLLIVER. 1993. Ibogaine induces glial activation in parasagittal zones of the cerebellum. NeuroReport 4: 299-302.
23. O'HEARN, E. & M. E. MOLLIVER. 1993. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 55: 303-310.
24. O'HEARN, E. O., P. ZHANG & M. E. MOLLIVER. 1995. Excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in Purkinje cells. NeuroReport 6: 1611-1616.
25. O'CALLAGAHAN, J. P. 1991. Quantification of glial fibrillary acidic protein: Comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13: 275-281.
26. PAGE, J. G., T. S. ROGERS, J. P. O'CALLAGAHAN & H. D. GILES. 1994. Acute neurotoxicity study of ibogaine HCl in dogs. NIDA Contract Report SRI-CHM-93-1034-7486-LXX.
27. MOLLIVER, M. E. & E. O'HEARN. 1995. Studies of ibogaine neurotoxicity in rat and monkey. Presented to the NIDA-Sponsored Ibogaine Review Meeting. March 1995.
28. VICTOR, M., R. ADAMS & E. L. MANCALL. 1959. A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch. Neurol. 1: 579-588.
29. KARHUNEN, P. J., T. ERKINJUNTTI & P. LAIPPALA. 1994. Moderate alcohol consumption and loss of cerebellar Purkinje cells. Br. Med. J. 308: 1663-1667.
30. SCHOLZ, E., H. C. DIENER, J. DICHGANS, H. D. LANGOHR, W. SCHIED & A. SCHUPMANN. 1986. Incidence of peripheral neuropathy and cerebellar ataxia in chronic alcoholics. J. Neurol. 233: 212-217.
31. STAPLETON, J. M., M. J. MORGAN, R. L. PHILLIPS, D. F. WONG, B. C. K. YUNG, E. K. SHAYA, R. F. DANNALS, X. LIU, R. L. GRAYSON & E. D. LONDON. 1995. Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology 13: 21-31.
32. VOLKOW, N. D., N. MULLANI, K. L. GOULD, S. ADLER & K. KRAJEWSKI. 1988. Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. Br. J. Psychiatry 152: 641-648.
33. HOLMAN, B. L., P. A. CARVALHO, J. MENDELSON, S. K. TEOH, R. NARDIN, E. HALLGRING, N. HEBBEN & K. A. JOHNSON. 1991. Brain perfusion is abnormal in cocaine-dependent polydrug users: A study using technetium-99m-HMPAO and ASPECT. J. Nucl. Med. 32: 1206-1210.
34. LIU, X., R. L. PHILLIPS, S. M. RESNICK, D. F. WONG, J. M. STAPLETON & E. D. LONDON. 1995. Magnetic resonance imaging reveals no ventriculomegaly in polydrug abusers. Acta Neurol. Scand. 92: 83-90.
35. LIU, X., J. A. MATOCHIK, J. L. CADET & E. D. LONDON. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Unpublished study.
36. KUHL, D. E., E. J. METTER, W. H. RIEGE & C. H. MARKHAM. 1984. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann. Neurol. 15: S119-S125.
37. MORRIS, E. D., R. E. FISHER, N. M. ALPERT, S. L. RAUCH & A. J. FISCHMAN. 1995. In vivo imaging of neuromodulation using positron emission tomography: Optimal ligand characteristics and task length for detection of activation. Human Brain Mapping 3: 35-55.
38. DEWEY, S. L., G. S. SMITH, J. LOGAN, J. D. BRODIE, P. SIMKOWITZ, R. R. MACGREGOR, J. S. FOWLER, N. D. VOLKOW & A. P. WOLF. 1993. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc. Natl. Acad. Sci. USA 90: 11816-11820.
39. 2 receptor in nonhuman primates. Synapse 10: 177-184.
40. LONDON, E. D., M. MCKINNEY, M. DAM, A. ELLIS & J. T. COYLE. 1984. Decreased cortical glucose utilization after ibotenate lesion of the rat ventromedial globus pallidus. J. Cereb. Blood Flow Metab. 4: 381-390.
41. MCKINNEY, M. & J. T. COYLE. 1982. Regulation of neocortical muscarinic receptors: Effects of drug treatment and lesions. J. Neurosci. 2: 97-105.
42. WENK, G. L. & D. S. OLTON. 1984. Recovery of neocortical choline acetyltransferase activity following ibotenic acid injection into the nucleus basalis of Meynert in rats. Brain Res. 293: 184-186.